Calviks AB (publ) (STO:CALVIK)
Sweden · Delayed Price · Currency is SEK 30.10
-1.70 (-5.35%)
At close: Aug 1, 2025
Sage Therapeutics Revenue
Calviks AB had revenue of 117.74M SEK in the quarter ending March 31, 2025, with 73.90% growth. This brings the company's revenue in the last twelve months to 456.94M, up 265.12% year-over-year. In the year 2024, Calviks AB had annual revenue of 406.91M with 451.55% growth.
Revenue (ttm)
456.94M
Revenue Growth
+265.12%
P/S Ratio
0.36
Revenue / Employee
1.06M
Employees
459
Market Cap
164.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 406.91M | 333.13M | 451.55% |
| Dec 31, 2023 | 73.78M | 31.53M | 74.61% |
| Dec 31, 2022 | 42.25M | 16.50M | 64.06% |
| Dec 31, 2021 | 25.75M | 10.69M | 70.94% |
| Dec 31, 2020 | 15.07M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 85.17B |
| Atlas Copco AB | 173.03B |
| AB Volvo | 500.08B |
| EQT AB | 30.08B |
| ASSA ABLOY AB | 152.95B |
| Skandinaviska Enskilda Banken AB | 78.55B |
| Sandvik AB | 121.46B |
| Swedbank AB | 72.19B |